Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 283,919 shares of BLFS, which is worth approximately $7.44 Million. The most recent transaction as insider was on Jan 03, 2023, when has been sold 10,000 shares (Common Stock) at a price of $18.26 per share, resulting in proceeds of $182,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 284K

10.73% 3M change

2.33% 12M change

Total Value Held $7.44 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2023	SELL Open market or private sale	$182,600 $18.26 p/Share	10,000 Reduced 3.8%	252,826 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	20,939 Added 7.11%	273,765 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$20,600 $2.06 p/Share	10,000 Added 3.8%	253,326 Common Stock
Dec 28 2022	SELL Open market or private sale	$12,032 $16.9 p/Share	712 Reduced 0.28%	252,826 Common Stock
Nov 29 2022	SELL Open market or private sale	$8,689 $19.93 p/Share	436 Reduced 0.17%	253,538 Common Stock
Nov 10 2022	SELL Open market or private sale	$2,478 $23.16 p/Share	107 Reduced 0.04%	253,974 Common Stock
Sep 29 2022	SELL Open market or private sale	$15,124 $23.02 p/Share	657 Reduced 0.26%	254,081 Common Stock
Aug 31 2022	SELL Open market or private sale	$9,962 $23.44 p/Share	425 Reduced 0.17%	254,738 Common Stock
Aug 14 2022	BUY Grant, award, or other acquisition	-	411 Added 0.16%	255,163 Common Stock
Aug 10 2022	SELL Open market or private sale	$2,595 $23.17 p/Share	112 Reduced 0.04%	254,752 Common Stock
Jul 29 2022	BUY Grant, award, or other acquisition	-	524 Added 0.21%	254,864 Common Stock
Jul 17 2022	BUY Grant, award, or other acquisition	-	635 Added 0.25%	254,340 Common Stock
Jul 03 2022	BUY Grant, award, or other acquisition	-	690 Added 0.27%	253,705 Common Stock
Jun 28 2022	SELL Open market or private sale	$10,461 $14.86 p/Share	704 Reduced 0.28%	253,015 Common Stock
Jun 19 2022	BUY Grant, award, or other acquisition	-	733 Added 0.29%	253,719 Common Stock
Jun 05 2022	BUY Grant, award, or other acquisition	-	735 Added 0.29%	252,986 Common Stock
May 27 2022	SELL Open market or private sale	$5,100 $14.53 p/Share	351 Reduced 0.14%	252,251 Common Stock
May 22 2022	BUY Grant, award, or other acquisition	-	786 Added 0.31%	252,602 Common Stock
May 13 2022	SELL Open market or private sale	$1,331 $12.32 p/Share	108 Reduced 0.04%	251,816 Common Stock
Apr 18 2022	SELL Open market or private sale	$339,927 $17.59 p/Share	19,325 Reduced 7.12%	251,924 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	-	45,726 Added 14.43%	271,249 Common Stock
Mar 29 2022	SELL Open market or private sale	$14,634 $22.24 p/Share	658 Reduced 0.29%	225,523 Common Stock
Mar 01 2022	SELL Open market or private sale	$9,797 $23.78 p/Share	412 Reduced 0.2%	205,152 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	21,029 Added 8.49%	226,593 Common Stock
Feb 10 2022	SELL Open market or private sale	$13,221 $29.38 p/Share	450 Reduced 0.22%	205,564 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account